Stryker Corporation (LON:0R2S)
London · Delayed Price · Currency is GBP · Price in USD 355.34
-1.47 (-0.41%)
Jan 29, 2026, 5:09 PM GMT
Stryker Market Cap
Stryker has a market cap or net worth of 99.35 billion as of January 29, 2026. Its market cap has decreased by -12.23% in one year.
Market Cap
99.35B
Enterprise Value
109.36B
Revenue
18.14B
Ranking
n/a
PE Ratio
45.38
Stock Price
355.34
Market Cap Chart
Since June 21, 1983, Stryker's market cap has increased from 126.05M to 99.35B, an increase of 78,720.04%. That is a compound annual growth rate of 16.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 99.35B | -0.52% |
| Dec 31, 2025 | 99.87B | -8.91% |
| Dec 31, 2024 | 109.64B | 22.74% |
| Dec 29, 2023 | 89.32B | 16.32% |
| Dec 30, 2022 | 76.79B | 3.07% |
| Dec 31, 2021 | 74.50B | 10.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.27B |
| GSK plc | 74.73B |
| Haleon | 33.54B |
| Smith & Nephew | 10.56B |
| Convatec Group | 4.54B |
| Hikma Pharmaceuticals | 3.47B |
| Genus | 1.99B |
| HUTCHMED (China) | 1.95B |